Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.2.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2020   74,536,000      
Balance at beginning of period at Dec. 31, 2020 $ 391,117 $ 7 $ 602,064 $ 1,435 $ (212,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   917,000      
Common stock issued pursuant to equity awards, net 16,566 $ 1 16,565    
Repurchase of common stock (in shares)   (75,000)      
Repurchase of common stock (2,673)   (2,673)    
Stock-based compensation 12,955   12,955    
Other comprehensive income (loss) (989)     (989)  
Net income 3,802       3,802
Balance at end of period (in shares) at Mar. 31, 2021   75,378,000      
Balance at end of period at Mar. 31, 2021 420,778 $ 8 628,911 446 (208,587)
Balance at beginning of period (in shares) at Dec. 31, 2020   74,536,000      
Balance at beginning of period at Dec. 31, 2020 391,117 $ 7 602,064 1,435 (212,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) (924)        
Net income 13,793        
Balance at end of period (in shares) at Sep. 30, 2021   76,735,000      
Balance at end of period at Sep. 30, 2021 457,543 $ 8 655,620 511 (198,596)
Balance at beginning of period (in shares) at Mar. 31, 2021   75,378,000      
Balance at beginning of period at Mar. 31, 2021 420,778 $ 8 628,911 446 (208,587)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,098,000      
Common stock issued pursuant to equity awards, net (338)   (338)    
Repurchase of common stock (in shares)   (120,000)      
Repurchase of common stock (4,464)   (4,464)    
Employee stock purchase plan (in shares)   113,000      
Employee stock purchase plan 2,635   2,635    
Stock-based compensation 13,966   13,966    
Other comprehensive income (loss) 357     357  
Net income 733       733
Balance at end of period (in shares) at Jun. 30, 2021   76,469,000      
Balance at end of period at Jun. 30, 2021 433,667 $ 8 640,710 803 (207,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   290,000      
Common stock issued pursuant to equity awards, net (104)   (104)    
Repurchase of common stock (in shares)   (24,000)      
Repurchase of common stock (1,008)   (1,008)    
Stock-based compensation 16,022   16,022    
Other comprehensive income (loss) (292)     (292)  
Net income 9,258       9,258
Balance at end of period (in shares) at Sep. 30, 2021   76,735,000      
Balance at end of period at Sep. 30, 2021 $ 457,543 $ 8 655,620 511 (198,596)
Balance at beginning of period (in shares) at Dec. 31, 2021 76,778,000 76,778,000      
Balance at beginning of period at Dec. 31, 2021 $ 489,198 $ 8 657,485 2,125 (170,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,037,000      
Common stock issued pursuant to equity awards, net 13,835   13,835    
Repurchase of common stock (in shares)   (440,000)      
Repurchase of common stock (26,297)   (26,297)    
Stock-based compensation 18,599   18,599    
Other comprehensive income (loss) (1,075)     (1,075)  
Net income 33,586       33,586
Balance at end of period (in shares) at Mar. 31, 2022   77,375,000      
Balance at end of period at Mar. 31, 2022 $ 527,846 $ 8 663,622 1,050 (136,834)
Balance at beginning of period (in shares) at Dec. 31, 2021 76,778,000 76,778,000      
Balance at beginning of period at Dec. 31, 2021 $ 489,198 $ 8 657,485 2,125 (170,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares) (564,449)        
Other comprehensive income (loss) $ (7,441)        
Net income $ 93,960        
Balance at end of period (in shares) at Sep. 30, 2022 78,565,000 78,565,000      
Balance at end of period at Sep. 30, 2022 $ 615,881 $ 8 697,649 (5,316) (76,460)
Balance at beginning of period (in shares) at Mar. 31, 2022   77,375,000      
Balance at beginning of period at Mar. 31, 2022 527,846 $ 8 663,622 1,050 (136,834)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   999,000      
Common stock issued pursuant to equity awards, net 310   310    
Minimum tax withholding on common stock issued (3,698)   (3,698)    
Repurchase of common stock (in shares)   (124,000)      
Repurchase of common stock (5,214)   (5,214)    
Employee stock purchase plan (in shares)   83,000      
Employee stock purchase plan 2,911   2,911    
Stock-based compensation 19,464   19,464    
Other comprehensive income (loss) (3,988)     (3,988)  
Net income 31,966       31,966
Balance at end of period (in shares) at Jun. 30, 2022   78,333,000      
Balance at end of period at Jun. 30, 2022 569,597 $ 8 677,395 (2,938) (104,868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   232,000      
Common stock issued pursuant to equity awards, net $ (56)   (56)    
Repurchase of common stock (in shares) 0        
Stock-based compensation $ 20,310   20,310    
Other comprehensive income (loss) (2,378)     (2,378)  
Net income $ 28,408       28,408
Balance at end of period (in shares) at Sep. 30, 2022 78,565,000 78,565,000      
Balance at end of period at Sep. 30, 2022 $ 615,881 $ 8 $ 697,649 $ (5,316) $ (76,460)